SAHIN, Fikrettin,TASLI, Pakize Neslihan,KIRBAS, Oguz Kaan,AVSAR APDIK, Ezgi,APDIK, Huseyin
申请号：
AU2018395740
公开号：
AU2018395740A1
申请日:
2018.12.17
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to production of a drug which is specific for SH- SY5Y neuroblastoma cancer by loading CAPE to microvesicles that the specialized skin cell leaves into the nutrient solution. The objective of the present invention is to provide a cell-specific targeted vesicle development by loading CAPE to the microvesicles obtained as a result of the culturing and subsequent specialization (differentiation) of the tissue cells； and to use CAPE at lower concentrations compared to the state of the art applications to minimize its toxicity to both the cells other than the targeted cells and the body.
